Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Neuroendocrine Tumour”

532 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 532 results

Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)WithdrawnNCT06090318
What this trial is testing

Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

Who this might be right for
Advanced Solid TumorCDKN2ANSCLC+7 more
Rain Oncology Inc
Testing effectiveness (Phase 2)Study completedNCT02305810
What this trial is testing

A Biological Prospective Study in Patients With Metastatic Pancreatic NETs Treated With Everolimus

Who this might be right for
Pancreatic Neuroendocrine Tumour Metastatic
European Institute of Oncology 54
Early research (Phase 1)Ended earlyNCT07121829
What this trial is testing

Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid TumorPilocytic Astrocytoma+7 more
Day One Biopharmaceuticals, Inc. 44
Testing effectiveness (Phase 2)Ended earlyNCT05169437
What this trial is testing

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Who this might be right for
Solid TumorBreast TumorColon Tumor, Malignant+9 more
Tempus AI 22
Not applicableStudy completedNCT01770405
What this trial is testing

Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract

Who this might be right for
Pancreatic CystPancreatic NeoplasmsPancreatic Adenoma+5 more
Mauna Kea Technologies 40
Testing effectiveness (Phase 2)Study completedNCT02162446
What this trial is testing

68Ga-OPS202 Study for Diagnostic Imaging of GEP NET

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumors
Ipsen 12
Not applicableNo Longer AvailableNCT01980732
What this trial is testing

68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Who this might be right for
Carcinoid TumorsIslet Cell (Pancreatic NET)Other Neuroendocrine Tumors
Andrei Iagaru
Not applicableWithdrawnNCT02309632
What this trial is testing

Pancreatic Cancer Screening of High-Risk Individuals in Arkansas

Who this might be right for
Pancreatic NeoplasmsPeutz-Jegher's SyndromeBRCA1 Gene Mutation+5 more
University of Arkansas
Early research (Phase 1)Ended earlyNCT02110563
What this trial is testing

Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma

Who this might be right for
Solid TumorsMultiple MyelomaNon-Hodgkins Lymphoma+3 more
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 50
Testing effectiveness (Phase 2)Study completedNCT05864144
What this trial is testing

SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more
Sensei Biotherapeutics, Inc. 98
Early research (Phase 1)Study completedNCT00844064
What this trial is testing

Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2

Who this might be right for
Pancreatic NeoplasmsMelanomaColorectal Neoplasms
Isarna Therapeutics GmbH 62
Testing effectiveness (Phase 2)UnknownNCT04913337
What this trial is testing

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
MesotheliomaGlioblastomaRenal Cell Carcinoma+12 more
NGM Biopharmaceuticals, Inc 179
Early research (Phase 1)Looking for participantsNCT07106827
What this trial is testing

GV20-0251 in Advanced or Refractory Solid Tumors

Who this might be right for
HCC - Hepatocellular CarcinomaCholangiocarcinomaMelanoma+5 more
West China Hospital 10
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Testing effectiveness (Phase 2)Ended earlyNCT01056601
What this trial is testing

Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy

Who this might be right for
Pancreatic Cancer
Masonic Cancer Center, University of Minnesota 7
Testing effectiveness (Phase 2)Study completedNCT01658436
What this trial is testing

BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy.

Who this might be right for
Pancreatic Neuroendocrine Tumors (pNET)
Novartis Pharmaceuticals 31
Not applicableStudy completedNCT04483349
What this trial is testing

Assessment of What Patients and Healthcare Providers Value

Who this might be right for
Gastric AdenocarcinomaPancreatic AdenocarcinomaPancreatic Neuroendocrine Carcinoma
M.D. Anderson Cancer Center 397
Testing effectiveness (Phase 2)Ended earlyNCT02315625
What this trial is testing

Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery

Who this might be right for
Neuroendocrine TumorsNeuroendocrine CarcinomaNeuroendocrine Neoplasms+2 more
National Cancer Institute (NCI) 16
Not applicableStudy completedNCT05476978
What this trial is testing

Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatitis, ChronicPancreatic Neuroendocrine Tumor+1 more
Huazhong University of Science and Technology 130
Next Page